Sandia National Laboratories

The portable system uses centrifugal microfluidics, with molecular tests deploying a visualization method that obviates the need for sample prep.

The new device rotates heating blocks to contact a stationary sample and is meant to be integrated with a plug-and-play digital microfluidics hub.

NEW YORK (GenomeWeb) ― Manipulating miniature droplets and subjecting them to high temperatures on an open digital microfluidic device leads to evaporation that can seriously disrupt concentration-dependent enzymatic reactions, like PCR.

Scientists and engineers at Sandia National Laboratories have built a prototype of a modular microfluidic library preparation platform that will allow users to process small numbers of DNA samples for next-gen sequencing in an automated fashion.

Sandia National Laboratories researchers have developed a new immunoassay platform called SpinDx that they say could offer substantial improvements over standard ELISAs in terms of cost, speed, and sensitivity.

Arrayit has been awarded two separate contracts for its microarray manufacturing services: one with the Centers for Disease Control and Prevention and another with Sandia National Laboratories.

Sandia Labs will use the technology to develop biosecurity microarray tools.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.